OVERALL SURVIVAL OF NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED BY STANDARD THERAPY IN COMPARISON TO STANDARD THERAPY PLUS TUMOR TREATING FIELDS

被引：0
|
作者：
Rulseh, Aaron [1 ]
Derner, Adam [1 ]
Sroubek, Jan [1 ]
Klener, Jan [1 ]
Vymazal, Josef [1 ]
机构：
[1] Na Homolce Hosp, Prague, Czech Republic
来源：
NEURO-ONCOLOGY | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CTNI-73
引用
收藏
页码：59 / 59
页数：1
相关论文
共 50 条
  • [31] Standard dose and dose-escalated radiation therapy are associated with favorable survival in select elderly patients with newly diagnosed glioblastoma
    Jackson, William C.
    Tsien, Christina I.
    Junck, Larry
    Leung, Denise
    Hervey-Jumper, Shawn
    Orringer, Daniel
    Heth, Jason
    Wahl, Daniel R.
    Spratt, Daniel E.
    Cao, Yue
    Lawrence, Theodore S.
    Kim, Michelle M.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2018, 138 (01) : 155 - 162
  • [32] Standard Dose and Dose-Escalated Radiation Therapy Are Associated with Favorable Survival in Select Elderly Patients with Newly Diagnosed Glioblastoma
    Jackson, W. C.
    Tsien, C.
    Junck, L.
    Leung, D.
    Hervey-Jumper, S.
    Orringer, D.
    Heth, J.
    Wahl, D. R.
    Spratt, D. E.
    Cao, Y.
    Lawrence, T. S.
    Kim, M. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E81 - E81
  • [33] Standard dose and dose-escalated radiation therapy are associated with favorable survival in select elderly patients with newly diagnosed glioblastoma
    William C. Jackson
    Christina I. Tsien
    Larry Junck
    Denise Leung
    Shawn Hervey-Jumper
    Daniel Orringer
    Jason Heth
    Daniel R. Wahl
    Daniel E. Spratt
    Yue Cao
    Theodore S. Lawrence
    Michelle M. Kim
    [J]. Journal of Neuro-Oncology, 2018, 138 : 155 - 162
  • [34] Updated Safety And Feasibility Study Of Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy For Newly Diagnosed Glioblastoma
    Grossman, R.
    Bokstein, F.
    Blumenthal, D.
    Limon, D.
    Ben Harosh, C.
    Ram, Z.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E668 - E668
  • [35] Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy for Newly Diagnosed Glioblastoma: A Prospective Safety and Feasibility Study
    Bokstein, Felix
    Blumenthal, Deborah
    Limon, Dror
    Ben Harosh, Carmit
    Ram, Zvi
    Grossman, Rachel
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [36] IN SITU DELIVERY OF TUMOR TREATING FIELDS THERAPY IN GLIOBLASTOMA PATIENTS
    Arle, Jeffrey
    Wong, Eric
    Korshoej, Anders
    Dokos, Socrates
    Bomzon, Ze'ev
    Carlson, Kristen
    [J]. NEURO-ONCOLOGY, 2019, 21 : 282 - 282
  • [37] A PHASE IB TRIAL OF CEDIRANIB IN ADDITION TO STANDARD TEMOZOLOMIDE AND RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Chi, Andrew S.
    Gerstner, Elisabeth R.
    Eichler, April F.
    Chea, Houng K.
    Shearer, Nancy
    Drappatz, Jan
    Wen, Patrick Y.
    Ivy, S. Percy
    Loeffler, Jay S.
    Sorensen, A. Gregory
    Jain, Rakesh K.
    Batchelor, Tracy T.
    [J]. NEURO-ONCOLOGY, 2009, 11 (06) : 946 - 947
  • [38] PREDICTION OF DISTANT RECURRENCE IN GLIOBLASTOMA PATIENTS TREATED WITH STANDARD THERAPY
    Chiranth, Shivani
    Trip, Anouk
    Christensen, Ib
    Grunnet, Kirsten
    Moller, Soren
    Hasselbalch, Benedikte
    Muhic, Aida
    Lassen, Ulrik
    Poulsen, Hans
    Urup, Thomas
    [J]. NEURO-ONCOLOGY, 2023, 25
  • [39] THE COST-EFFECTIVENESS OF TUMOR-TREATING FIELDS IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Armoiry, X.
    Auguste, P.
    Dussart, C.
    Guyotat, J.
    Connock, M.
    [J]. NEURO-ONCOLOGY, 2019, 21 : 68 - 68
  • [40] SurVaxM with standard therapy in newly diagnosed glioblastoma: Phase II trial update.
    Ahluwalia, Manmeet Singh
    Reardon, David A.
    Abad, Ajay P.
    Curry, William T.
    Wong, Eric T.
    Belal, Ahmed
    Qiu, Jingxin
    Mogensen, Kathleen
    Schilero, Cathy
    Hutson, Alan
    Casucci, Danielle
    Mechtler, Laszlo
    Uhlmann, Erik J.
    Ciesielski, Michael J.
    Fenstermaker, Robert
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345